Anti-HIV drug based on U research wins FDA approval
Biochemist Wesley Sundquist studied the virus’ molecular structure and wound up discovering its Achilles heel.
Read MoreBiochemist Wesley Sundquist studied the virus’ molecular structure and wound up discovering its Achilles heel.
Read MoreThe honor is in recognition of the biochemist’s research to understand the structure of HIV that led to the drug lenacapavir, which is nearly 100% effective against HIV.
Read MoreWesley Sundquist conducted basic research that led to the drug lenacapavir, “a pivotal step toward diminishing HIV/AIDS as a global health crisis.”
Read MoreA University of Utah Health-led multi-institutional research center that studies the inner workings and vulnerabilities of HIV recently received a five-year, $28 million grant renewal from the National Institutes of Health.
Read More“Pioneering the Future” digital collection celebrates scientists carrying on a tradition of excellence.
Read MoreThe “Utah Women 2020” mural in downtown Salt Lake City, commemorating the 100-year anniversary of the 19th Amendment, features more than 250 women, including University of Utah alumni, faculty and staff.
Read MoreOn the 30th anniversary of a landmark AIDS research bill, four U researchers reflect on the history of HIV/AIDS research and treatment in Utah.
Read MoreThe new technique can track molecules in real time, at room temperature, with impressive resolution.
Read MoreA look at how a virus and its molecules interact with human cells.
Read MoreDuring the 2018 Sundance Film Festival, a documentary will premiere depicting the courageous story of physician Kristen Reis, a retired U professor, and her partner (both in life and work) Maggie Snyder. “Quiet Heroes” depicts Reis’ selfless career as the first doctor in Utah to treat HIV/AIDS patients at a time when others cruelly turned them away.
Read MoreU researchers Saveez Saffarian and Mourad Bendjennat believe Protease might become a friend instead of foe in fighting HIV.
Read More